Literature DB >> 6302557

Amiodarone neuropathy.

A Martinez-Arizala, S M Sobol, G E McCarty, B R Nichols, L Rakita.   

Abstract

Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%). Although the neuropathy may be severe, it tends to improve with lowering of the dosage or discontinuation of the medication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302557     DOI: 10.1212/wnl.33.5.643

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Peripheral neuropathy during longterm high-dose amiodarone therapy.

Authors:  A G Fraser; I N McQueen; A H Watt; M R Stephens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

2.  Ataxia: a diagnostic perplexity and management dilemma.

Authors:  Vinod K Chaubey; Lovely Chhabra; Aaysha Kapila
Journal:  BMJ Case Rep       Date:  2013-09-26

3.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

4.  Myopathy during amiodarone treatment: a case report.

Authors:  F Carella; E Riva; L Morandi; E Cappiello; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1987-12

5.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

Review 6.  Neurologic complications of cardiovascular diseases.

Authors:  W R Slade; A C McNeal; P S Tse
Journal:  J Natl Med Assoc       Date:  1989-02       Impact factor: 1.798

Review 7.  Amiodarone: A Newly Discovered Association with Bilateral Vestibulopathy.

Authors:  Robert Gürkov
Journal:  Front Neurol       Date:  2018-03-06       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.